For a decade, Creative Biolabs is dedicated to providing antibody engineering services to many clients in need. Empowered by our comprehensive platforms and portfolios, our scientists are at the top in the field and experience in discovering and developing novel therapeutic. Next-IO™ Anti-CD94/NKG2A Monoclonal Antibody Program aims to develop novel therapeutic antibody candidates for cancer patients in need.
Learn more: https://www.creative-biolabs.com/immuno-oncology/anti-cd94-nkg2a-monoclonal-antibody-program.htm
Copyright 2019 © P-tweets Refunds